HPC

HM Payson & Co Portfolio holdings

AUM $5.7B
1-Year Return 8.86%
This Quarter Return
-2.06%
1 Year Return
+8.86%
3 Year Return
+37.55%
5 Year Return
+149.98%
10 Year Return
+262.8%
AUM
$4.27B
AUM Growth
-$188M
Cap. Flow
-$42.4M
Cap. Flow %
-0.99%
Top 10 Hldgs %
34.14%
Holding
1,062
New
68
Increased
229
Reduced
210
Closed
62
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
FNLC icon
276
First Bancorp
FNLC
$305M
$453K 0.01%
19,294
-607
-3% -$14.3K
OZK icon
277
Bank OZK
OZK
$5.9B
$445K 0.01%
12,000
EFA icon
278
iShares MSCI EAFE ETF
EFA
$66.2B
$443K 0.01%
6,425
ROST icon
279
Ross Stores
ROST
$49.4B
$439K 0.01%
3,886
IWV icon
280
iShares Russell 3000 ETF
IWV
$16.7B
$439K 0.01%
1,790
AGCO icon
281
AGCO
AGCO
$8.28B
$438K 0.01%
3,700
TEL icon
282
TE Connectivity
TEL
$61.7B
$437K 0.01%
3,540
+810
+30% +$100K
WDAY icon
283
Workday
WDAY
$61.7B
$435K 0.01%
2,025
VV icon
284
Vanguard Large-Cap ETF
VV
$44.6B
$428K 0.01%
2,186
EW icon
285
Edwards Lifesciences
EW
$47.5B
$413K 0.01%
5,958
+2,040
+52% +$141K
CE icon
286
Celanese
CE
$5.34B
$408K 0.01%
3,250
GNRC icon
287
Generac Holdings
GNRC
$10.6B
$405K 0.01%
3,721
+200
+6% +$21.8K
RSG icon
288
Republic Services
RSG
$71.7B
$402K 0.01%
2,820
BSX icon
289
Boston Scientific
BSX
$159B
$402K 0.01%
7,606
+2,236
+42% +$118K
VNQ icon
290
Vanguard Real Estate ETF
VNQ
$34.7B
$401K 0.01%
5,295
-345
-6% -$26.1K
ETN icon
291
Eaton
ETN
$136B
$395K 0.01%
1,851
-50
-3% -$10.7K
ESGD icon
292
iShares ESG Aware MSCI EAFE ETF
ESGD
$9.93B
$386K 0.01%
5,578
+5,303
+1,928% +$367K
APH icon
293
Amphenol
APH
$135B
$383K 0.01%
9,124
MRO
294
DELISTED
Marathon Oil Corporation
MRO
$382K 0.01%
14,270
AMD icon
295
Advanced Micro Devices
AMD
$245B
$380K 0.01%
3,694
-71
-2% -$7.3K
MKC icon
296
McCormick & Company Non-Voting
MKC
$19B
$380K 0.01%
5,020
AWK icon
297
American Water Works
AWK
$28B
$379K 0.01%
3,063
CLX icon
298
Clorox
CLX
$15.5B
$366K 0.01%
2,792
+400
+17% +$52.4K
IWR icon
299
iShares Russell Mid-Cap ETF
IWR
$44.6B
$362K 0.01%
5,227
+2,400
+85% +$166K
NVO icon
300
Novo Nordisk
NVO
$245B
$357K 0.01%
3,926